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Dendritic cell (DC) migration to secondary lymphoid
organs is a critical step to properly exert its role in immu-
nity and predominantly depends on the interaction of the
chemokine receptor CCR7 with its ligands CCL21 and
CCL19. Polysialic acid (PSA) has been recently reported
to control CCL21-directed migration of mature DCs. Here,
we first demonstrate that PSA present on human mature
monocyte-derived dendritic cells did not enhance chemo-
tactic responses to CCL19. We have also explored the
molecular mechanisms underlying the selective enhancing
effect of PSA on CCL21-driven chemotaxis of DCs. In this
regard, we found out that prevention of DC polysialylation
decreased CCL21 activation of JNK and Akt signaling
pathways, both associated with CCR7-mediated chemotax-
is. We also report that the enhanced PSA-mediated effect
on DC migration towards CCL21 relied on the highly basic
C-terminal region of this chemokine and depended on the
PSA acceptor molecule neuropilin-2 (NRP2) and on the
polysialyltransferase ST8SiaIV. Altogether, our data indi-
cate that the CCR7/CCL21/NRP2/ST8SiaIV functional
axis constitutes an important guidance clue for DC target-
ing to lymphoid organs.
Keywords: CCL21/chemotaxis /dendritic cells /neuropilin-2/
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Introduction
Dendritic cells (DCs) are bone marrow-derived cells absolutely
required for the proper generation of adaptive immunity and tol-
erance. Upon antigen recognition, immature DCs localized in
the peripheral tissue acquire the ability to act as antigen present-
ing cells and home to T-cell zones of lymphoid organs where
they stimulate antigen-speciﬁc naïve T cells (Steinman and
Banchereau 2007). Acquisition of the DC immuno-competent
phenotype is achieved by a ﬁnely regulated genetic program
that modulates the expression of many genes required to accom-
plish DC immune functions eﬀectively. Among them, induction
of expression of the chemotactic receptor CCR7 provides DCs
the major guidance clue to traﬃc towards lymphoid organs
(Forster et al. 1999). Chemokines CCL21 and CCL19 induce
CCR7-mediated G protein activation, which indeed triggers
the multiple signaling modules required for the mobilization
of DCs to lymphoid tissues (Randolph et al. 2008). Besides
CCR7, other accessory cell surface proteins, such as CD38, and
the PGE2 receptors EP2 and EP4 are also known to inﬂuence
DC migration to secondary lymphoid organs (Randolph et al.
2005).
Polysialic acid 2,8-linked N-acetylneuraminic acid (PSA) is
a large linear homopolymer post-translationally added to a
small number of proteins (Muhlenhoﬀ et al. 1998). On the
major carrier protein NCAM, PSA plays a critical role in the
development of the vertebrate nervous system (Rutishauser
2008), where it controls neuronal and olygodendrocyte migration
and alters cell–cell and cell–extracellular matrix interactions.
PSA also regulates migration of T-cell progenitors from the bone
marrow to the thymus (Drake et al. 2009). Two polysialyltrans-
ferases (ST8SiaII and IV) are known to be responsible for the
polysialylation of NCAM and other acceptor molecules (Angata
and Fukuda 2003). The expression of the polysialyltransferase
ST8SiaIV is induced in mature DCs, where it is likely involved
in synthesizing PSA on O-linked glycans of the 130-kDa mem-
brane glycoprotein neuropilin-2 (NRP2), whose expression is
also upregulated during DC maturation (Curreli et al. 2007).
Polysialylation in DCs has been demonstrated to contribute to
T-cell allostimulation (Curreli et al. 2007). More recently, it
has been reported that PSA controls CCL21-directed migration
of mature DCs (Bax et al. 2009), although its role in CCL19-
driven chemotaxis has not been explored yet. NRP2, through
binding to its structurally unrelated ligands, semaphorins B, C
and F, and some members of the VEGF family, has been impli-
cated in cell motility, including neuronal growth cone collapse
and endothelial and tumor cell migration (Geretti et al. 2008;
Pellet-Many et al. 2008). The expression of PSA and NRP2 in
mature DCs and their involvement in cell migration prompted us
to investigate their roles in CCR7-mediated DC chemotaxis.
In this work, we show that PSA has no enhancing eﬀect on
human DC migration towards CCL19. We also report that pre-
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vention of DC polysialylation decreases CCL21-triggered acti-
vation of the CCR7-chemotaxis-associated JNK and Akt
signaling pathways. Moreover, our results indicate that the
PSA enhancing eﬀect on CCL21-driven chemotaxis of DCs
depends on the highly basic C-terminal region of the chemo-
kine and is mediated by the PSA acceptor glycoprotein NRP2.
Results
PSA selectively enhances mature DC chemotaxis towards
CCL21 but not towards CCL19
PSA was recently shown to enhance migration in response to
CCL21 of lipopolysaccharide (LPS)-induced mature DCs (Bax
et al. 2009). We wondered if this eﬀect was also shared by
CCL19, the other CCR7 ligand. For this purpose, LPS-matured
human DCs were treated with the EndoN enzyme to remove
surface PSA, and their ability to migrate towards CCL21 or
CCL19 was compared with that displayed by untreated DCs.
EndoN treatment resulted in complete PSA removal, as
assayed by western blotting (Figure 1A, upper panel, compare
lines 1 and 2) and ﬂow cytometry (Figure 1A, lower panel).
PSA content recovery was measured at distinct times after
EndoN treatment to assure that no signiﬁcant PSA re-expression
occurs during the chemotaxis assays. In this regard, less than
20% of PSA content was recovered 8 h after DC-EndoN
treatment, a time that exceeded the 2-h period of time
required to complete the chemotaxis experiments (Figure 1A,
upper panel). Chemotaxis assays in response to each chemo-
kine revealed that EndoN-treated DCs showed signiﬁcant
reduced migration towards CCL21 (average percentage of mi-
gration of EndoN-treated DCs with respect to untreated DCs
was 52%, P = 0.000045, N = 19), but not towards CCL19
(average percentage of migration of EndoN-treated DCs with
respect to untreated DCs was 92%, P = 0.37, N = 15)
(Figure 1B). Interestingly, reduction of migration towards
CCL21 after PSA removal was even stronger when subopti-
mal doses of CCL21 were used (average percentage of
migration of EndoN-treated DCs with respect to untreated
DCs was 27%, P = 0.009, N = 4) (Figure 1C). Addition of
CCL21 to both the upper and the lower chambers of the mi-
gration transwells revealed no diﬀerences in the number of
DCs that migrated to the lower chambers when EndoN-
treated and non-treated DCs were compared, which indicated
that the eﬀects of PSA were exerted on CCL21-dependent
chemotaxis and not on migratory speed (unpublished data).
Moreover, EndoN treatment of DCs did not modify CCR7
expression levels as determined by western blotting
(Figure 1D) and ﬂow cytometry (Figure 1E). The absence
of diﬀerences in the CCR7 molecular size between EndoN-
treated and untreated DCs (Figure 1D) strongly suggests that
CCR7 is not polysialylated. The above data indicate that cell
surface PSA does not aﬀect migration of mature DCs towards
CCL19, implying that PSA selectively contributes to CCL21-
directed DC migration.
Removal of PSA in DCs decreases CCL21-induced
CCR7-mediated signaling
CCL21 triggers CCR7-mediated G protein activation that
results in the activation of multiple signaling pathways
(Randolph et al. 2008). Of them, JNK activation has been
associated with DC migration in response to chemokines
(Iijima et al. 2005; Riol-Blanco et al. 2005) and Akt activation
with promotion of DC migration (Del Prete et al. 2004) and
survival (Sanchez-Sanchez et al. 2004). To examine the signal-
ing pathways underlying the PSA-mediated enhancement of
CCL21-directed chemotaxis, CCL21-induced JNK and Akt
phosphorylation levels were compared between EndoN-treated
and untreated mature DCs. While more pronounced transient
JNK and Akt phosphorylations were observed in untreated
DCs than in EndoN-treated DCs upon stimulation with
CCL21 (Figure 2A), no diﬀerences were observed upon stim-
ulation with CCL19 (Figure 2B). These results indicate that
PSA enhances CCL21-driven signaling likely through CCR7
and are consistent with the increased migration towards
CCL21 observed in PSA-bearing DCs with respect to DCs
devoid of PSA.
PSA enhancement of CCL21-driven chemotaxis relies on the
highly basic C-terminal amino acid region of the chemokine
As shown before and unlike the case of CCL21, no PSA-
enhancement eﬀect on CCL19-directed chemotaxis was
observed (Figure 1B). A striking structural diﬀerence between
CCL21 and CCL19 is the presence of a highly basic C-terminal
32-amino-acid-long region in CCL21, which is absent in
CCL19 (Figure 3A). This region has been suggested to interact
with glycosaminoglycans to mediate the sequestration of
CCL21 in endothelial cells to facilitate the formation and main-
tenance of the CCL21 gradient (Hirose et al. 2002). In this
regard, highly negatively charged PSA present on polysialy-
lated proteins in DCs is likely to interact with the basic
C-terminal region of CCL21. Such an interaction would resem-
ble the interaction of CCL21 with negatively charged
glycosaminoglycans (Hirose et al. 2002) and sulfated chains
coupled to PSGL-1 on T cells (Veerman et al. 2007). Further-
more, the cationic neurotrophic factors brain-derived
neurotrophic factor, nerve growth factor, neurotrophin-3 and
neurotrophin-4 have been demonstrated to directly interact
with PSA (Kanato et al. 2008). Interestingly, PSA coupled to
biotinylated polyacrylamide has been recently shown to inter-
act with CCL21 in vitro (Bax et al. 2009). The above reasoning
prompted us to test whether the basic C-terminal region of
CCL21 contributes to the PSA eﬀect on CCL21-directed
chemotaxis. To that end, a CCL21 mutant lacking the last 32
C-terminal amino acid residues (designated as St CCL21-stop)
was generated and expressed in the supernatants of transfected
COS-7 cells. As a control, a CCL21 full-length form was also
produced in COS7 cells (referred to as St CCL21 wt). Both
proteins displayed the expected molecular sizes as determined
by western blotting on supernatants of transfected COS7 cells
using a CCL21 speciﬁc antibody (Figure 3B). Recombinant
CCL21, St CCL21 wt and St CCL21-stop were then compared
in their chemotaxis-inducing ability on untreated and EndoN-
treated mature DCs. As shown in Figure 3C, untreated DCs
migrated better than EndoN-treated DCs to both recombinant
CCL21 and St CCL21 wt. However, no diﬀerences in migra-
tion between untreated and EndoN-treated DCs towards St
CCL21-stop were evidenced (Figure 3C). Thus, like for
CCL19, St CCL21-stop-driven DC chemotaxis is not sensitive
to PSA removal. Taken together, these observations indicate
that the C-terminal region of CCL21 contributes to the in-
1140
A Rey-Gallardo et al.
 at Centro de Inform
aciÃ³n y DocumentaciÃ³n CientÃ-fica on August 1, 2016
http://glycob.oxfordjournals.org/
D
ow
nloaded from
 
creased migration observed in PSA-bearing DCs towards this
chemokine and provides a suitable molecular explanation of
why PSA does not aﬀect migration of DCs towards CCL19.
Polysialylated NRP2 regulates CCL21-driven migration
of DCs
Polysialylation of NRP2 in DCs and its role in endothelial and
tumor cell migration (Geretti et al. 2008; Pellet-Many et al.
2008) induced us to investigate its contribution to CCL21-
and CCL19-driven DC migration by using siRNA technology
to knock down its polysialylation (by ST8SiaIV siRNA) and
expression (by NRP2 siRNA). Eﬀective downregulation of
ST8SIAIV expression in DCs after siRNA nucleofection was
evidenced in all experiments performed by an almost complete
abrogation of cellular PSA content (Figure 4A, left panel) and
by the shift of the smear corresponding to the NRP2 into a
sharper and smaller size band, a feature consistent with the
removal of the NRP2-attached PSA chains (Figure 4A, right
panel). Downregulation of ST8SiaIV expression resulted in a
Fig. 1. PSA on DCs enhances their chemotaxis to CCL21 but not to CCL19. (A) Upper panel. Removal of PSA from mature DCs by EndoN treatment.
Time course of PSA content recovery after EndoN treatment of DCs. Mature DCs (line 1) were treated with EndoN (line 2) as indicated in experimental procedures
and cultured in complete medium for the times indicated (lines 3 to 5). Cell lysates were obtained and probed by western blotting with the antibody 735.
Blots were stripped and probed for tubulin levels as a control for protein loading. The time course experiment shown is representative of two independent
experiments. Lower panel. Cell surface expression of PSA on untreated (left panel) and EndoN-treated (right panel) DCs was determined by ﬂow cytometry using
the antibody 735 (continuous line). P3X63 antibody was used as a negative control (gray line). A representative experiment is shown. (B) Average percentage
of migration to 200 ng/mL of CCL21 and of CCL19 of untreated (black bars) and EndoN-treated mature DCs (gray bars) generated from 19 independent donors
for CCL21 and from 15 donors for CCL19. Mean values and SEM are represented. *P less than 0.05 (Student’s paired t-test). (C) Percentage of migration to
50 ng/mL of CCL21 of untreated (black bars) and EndoN-treated mature DCs (gray bars) generated from four independent donors. (D) Expression of CCR7 in
mature DCs untreated or treated with EndoN from four independent donors (each denoted by the horizontal line shown below), as determined by western blotting.
Blot was stripped and probed for tubulin levels as a control for protein loading. (E) Representative experiment for the determination of cell surface CCR7
expression measured by ﬂow cytometry on mature DCs untreated or treated with EndoN. The percentage of positive cells (lower number) and the mean
ﬂuorescence intensity (upper number) are shown.
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Fig. 2. JNK and Akt signaling after CCL21 stimulation is reduced in EndoN-treated DCs. Mature DCs were treated with CCL21 (200 ng/mL) (panel A) or
CCL19 (200 ng/mL) (panel B) for the indicated times. Levels of active forms of JNK and Akt in cell lysates were determined by western blotting. Blots were
stripped and probed for actin or tubulin levels as controls for protein loading. Data shown are representative of three independent experiments.
Fig. 3. The basic C-terminal region of CCL21 contributes to the PSA-enhanced chemotaxis. (A) Alignment of sequences for human CCL21 and CCL19.
Basic residues within the C-terminal region of CCL21 are represented in bold. (B) Characterization of st CCL21 wt and st CCL21-stop forms. Supernatants of
COS7 cells transfected with vectors pcDNA3.1 (mock), pVAX-CCL21 (St CCL21 wt) and pVAX-CCL21-stop (St CCL21-stop) and recombinant CCL21
(20 ng) were subjected to SDS-PAGE and western blotting and detected with an antibody against human CCL21. (C) Average percentage of migration towards
recombinant CCL21, St CCL21 wt and St CCL21-stop of untreated (black bars) and EndoN-treated mature DCs (gray bars). Recombinant CCL21 was used
at 200 ng/mL, and St CCL21wt and St CCL21-stop forms were used at doses estimated to be within a range between 100 and 200 ng/mL. Data were derived
from three independent donors. Mean values and SEM are represented. *P less than 0.05 (Student’s paired t-test).
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drastic drop of migration towards CCL21 but, in agreement
with our former results, not towards CCL19 (Figure 4B).
These results corroborate our previous conclusions by a dif-
ferent experimental approach and demonstrate that the
enzyme ST8SiaIV mediates the incorporation of the PSA
moieties implicated in CCL21-directed DC migration.
Since ST8SiaIV knockdown dramatically reduced the poly-
sialylation extent of NRP2, we next investigated the inﬂuence
of NRP2 expression on DC migration towards CCL21 and
CCL19. Nucleofection of NRP2 siRNA in DCs resulted in
reduction of NRP2 expression levels of 15%, 34% and 80%
in three independent experiments with respect to those found
in DCs nucleofected with GAPDH siRNA (Figure 4A) and led
to a signiﬁcant hampered migration of DCs towards CCL21
but not towards CCL19 (Figure 4A and B). The greater knock-
down eﬃciency of ST8SiaIV siRNA with respect to NRP2
siRNA might explain why the eﬀects in migration were more
drastic in DCs nucleofected with the former siRNA. Since
neither ST8SiaIV nor NRP2 siRNAs modiﬁed CCR7 expres-
sion levels (Figure 4C), the above results indicate that
polysialylated NRP2 speciﬁcally controls CCL21-directed
chemotaxis of DCs.
Discussion
This report provides evidence that PSA removal from mature
DCs either by EndoN treatment or by knocking down the poly-
sialyltransferase ST8SIAIV impairs their ability to migrate
towards CCL21 but not towards CCL19. Our results, besides
reinforcing the data reported by Bax et al. (2009): (1) show that
prevention of DC polysialylation impaired CCL21 activation of
CCR7-migration-associated JNK and Akt signaling pathways,
(2) highlight the critical role of the highly basic C-terminal
region of the CCL21 chemokine for the PSA-enhancement
eﬀect on DC chemotaxis towards CCL21 and (3) demonstrate
the contribution of the PSA acceptor molecule NRP2 to mature
DC migration towards CCL21.
Since our experiments used LPS-induced mature DCs, a
Toll-like receptor (TLR)-4-dependent maturation model, it
should be investigated whether the enhanced PSA-mediated
Fig. 4. Downregulation of the polysialyltransferase ST8SiaIV and NRP2 in mature DCs selectively and negatively aﬀect their chemotaxis towards CCL21.
(A) Western blotting was used to determine the expression levels of PSA (with the antibody 735) (left panel) and NRP2 (right panel) on untreated mature DCs and
mature DCs nucleofected DCs with siRNAs for GAPDH (referred to as Cont), ST8SiaIV and NRP2. Blots were stripped and probed for actin levels as a
control for protein loading. Band observed in left panel around 150 kDa corresponds to NRP2. A representative experiment out of three is shown. (B) Average
percentage of migration to 200 ng/mL of CCL21 (left panel) and CCL19 (right panel) of mature DCs, obtained from three independent donors, nucleofected with the
indicated siRNAs. Mean values and SEM are represented. For statistical analysis, data for migration of DCs nucleofected with ST8SiaIV and NRP2 siRNAs
were independently compared with those obtained for DCs nucleofected with GAPDH siRNA (referred to as Cont). *P less than 0.05 (Student’s paired t-test).
(C) CCR7 expression in untreated mature DCs and mature DCs nucleofected with GAPDH, NRP2 and ST8SiaIV siRNAs was determined by western blotting. Blots
were stripped and probed for tubulin levels as a control for protein loading. The experiment shown is representative of three independent experiments.
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eﬀect on DC migration towards CCL21 operates upon DC
maturation triggered through activation of other TLR.
Interestingly, selective enhancement of CCL21-mediated
chemotaxis might provide clues about the diﬀerential eﬀects
of CCL21/CCL19 on CCR7 recycling/degradation, desensiti-
zation and signaling (Kohout et al. 2004; Otero et al. 2006).
Plasma membrane glycoprotein NRP2 has been identiﬁed
as a PSA acceptor in mature DCs (Curreli et al. 2007). Our
experiments show that downregulating NRP2 expression (by
NRP2 siRNA) or impairing its polysialylation (either by
EndoN treatment or by ST8SiaIV siRNA) led to a signiﬁcant
reduction of DC migration towards CCL21. Altogether, these
results point out that the PSA present on the structural context
of NRP2 contributes to DC chemotaxis towards CCL21.
Nevertheless, although western blotting analysis of lysates
from mature DCs identiﬁed NRP2 as the most abundant poly-
sialylated protein (Curreli et al. 2007 and our data), the
contribution of other so far uncharacterized polysialylated
acceptor proteins cannot be ruled out.
Besides mature DCs, NRP2 is preferentially expressed on
lymphatic endothelial cells and some tumors, where it acts as
a co-receptor for semaphorins 3B, C and F and some member
of the VEGF family through their interactions with the signal-
transducing receptors Plexins and VEGFR, respectively. Those
interactions license NRP2 to contribute to neurogenesis, lym-
phangiogenesis and tumor progression via its key roles in axon
guidance and endothelial and tumor migration and survival
(Favier et al. 2006; Geretti et al. 2008; Pellet-Many et al.
2008). Our ﬁnding is consistent with the role of NRP2 in mi-
gration and adds novel perspectives of interest with regard to
its post-translational modiﬁcation by PSA and its functional
cooperation with a chemokine receptor.
Finally, we have demonstrated that PSA-enhanced chemo-
taxis to CCL21 relies on its highly basic C-terminal region.
This ﬁnding provides a structural framework that helps to
explain why the PSA-enhancing eﬀects on CCL21-directed
DC chemotaxis were not seen for CCL19 (Figure 5). The bind-
ing of CCL21 to PSA (Bax et al. 2009) and of its C-terminal
basic region to glycosaminoglycans (Hirose et al. 2002), in
combination with our experimental data, make it reasonable
to propose that the C-terminal basic region of CCL21 binds
NRP2-coupled PSA. This interaction would presumably leave
the N-terminal portion of the chemokine available (the region
of chemokines known to be required for receptor binding (Allen
et al. 2007)), to interact with CCR7. According to this model,
PSA-NRP2 would trap CCL21, increasing the local concentra-
Fig. 5. Working structural model of the CCR7/PSA-NRP2/CCL21 functional axis. See the text for explanations. PSA on the NRP2 structure was arbitrarily
positioned, since the region within the NRP2 structure where PSA is attached is so far unknown.
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tion of the chemokine and/or enabling a proper CCL21-CCR7
docking. In any case, the formation of the ternary functional
CCR7/PSA-NRP2/CCL21 complex could result in a lowering
of the activation threshold of CCR7 and therefore in an
increase of CCR7-mediated JNK and Akt signaling pathways.
The higher eﬀect on PSA-enhanced migration observed at
lower doses of CCL21 supports the model proposed, which is
reminiscent of the one proposed for the simultaneous binding of
VEGF to neuropilins and VEGF receptors, and the enhancing
eﬀect of neuropilins on cell migration (Favier et al. 2006;
Staton et al. 2007). In addition, binding of PSA-NRP2 to
CCL21 might favor dimerization of the chemokine, protect
it from proteolysis and/or enhance CCR7-independent signal-
ing through NRP2-mediated signaling by itself or through its
co-receptors, Plexins and/or VEGF receptors. Clearly, further
investigation is required to unravel all of the above issues.
The absence of a basic C-terminal region in CCL19 and in
the St CCL21-stop mutant would preclude its interaction with
PSA-NRP2 and therefore its integration in the CCR7/NRP2/
ST8SiaIV axis.
A direct association of CCR7 expression with lymph node
metastasis in cancer patients has been found in a large variety
of solid tumors (Zlotnik 2006). On the other hand, NRP2 has
been implicated in mediating proliferation, survival and migra-
tion of tumor cells (Bielenberg et al. 2006; Gray et al. 2008),
and PSA has been demonstrated to facilitate tumor invasion
(Suzuki et al. 2005). The functional cooperation reported here
between CCR7, NRP2 and ST8SiaIV prompts further investi-
gation of the relevance of this axis in tumors cell types that
preferentially metastasize to secondary lymphoid organs.
Materials and methods
Reagents
CCL21 and CCL19 chemokines were obtained from Prepro-
Tech. Antibodies against human CCL21, NRP2 and CCR7-
phycoerythrin (for ﬂow cytometry) were from R&D Systems.
Anti-CCR7 for western blotting was obtained from AbCam.
For PSA detection, the monoclonal antibody 735 was used
(Frosch et al. 1985). The anti-phospho-JNK(Thr183/Tyr185)
and anti-phospho-Akt(Ser473) antibodies were purchased from
Cell Signaling. Antibodies against actin and tubulin were
from Sigma.
Generation of monocyte-derived dendritic cells
Monocyte-derived dendritic cells were generated from periph-
eral blood mononuclear cells of healthy donors as described
(Puig-Kroger et al. 2006). For maturation, immature DCs were
treated with 100 ng/mL of LPS (Escherichia coli 0111:B4,
InvivoGen) for 48 h. Acquisition of the DC mature pheno-
type was checked by ﬂow cytometry using antibodies
against CD83, CD86, CD209 and PSA.
EndoN treatment of DCs
EndoN was puriﬁed as described (Hallenbeck et al. 1987).
Mature DCs at 2 × 106 cells/mL were incubated for 1 h at
37°C with either 5 U of EndoN at 1 U/mL (referred to as
mDC-EndoN) or an equal volume of phosphate-buﬀered
saline/glycerol in RPMI 1640, with occasional shaking.
Afterwards, cells were washed with complete medium.
PSA removal after EndoN treatment was tested in all DCs
preparations by western blotting and occasionally by ﬂow
cytometry using the monoclonal antibody 735.
Western blotting
Western blots were essentially performed as described (Puig-
Kroger et al. 2006). Brieﬂy, 10 µg of each lysate were subjected
to sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) under reducing conditions and transferred onto
an Immobilon polyvinylidene diﬂuoride membrane (Millipore).
ImageJ software was used for gel quantiﬁcation analysis.
Site-directed mutagenesis of CCL21 and expression of CCL21
plasmids in COS7 cells
Site-directed mutagenesis was performed on the pVAX-CCL21
construct (kindly provided by Dr. Y. Zhao, Medical Research
Center, Shandong Provincial Hospital, Shandong University,
Jinan (Li et al. 2006)) using the QuikChange System (Strata-
gene). For the introduction of a stop codon in amino Cys 103
of human CCL21, the oligonucleotides GAAACCAGCC-
CAGGGCTGAAGGAAGGACAGGGGGG, sense, and
CCCCCCTGTCCTTCCTTCAGCCCTGGGCTGGTTTC,
antisense, were used. This mutation gave rise to a CCL21 pro-
tein 31 amino acids shorter than the full-length form. The
mutations of the resulting plasmid, designated as pVAX-
CCL21-stop, were conﬁrmed by DNA sequencing.
Vectors pcDNA3.1, pVAX-CCL21 and pVAX-CCL21-stop
were transfected in COS7 cells by using Lipofectamine 2000
as recommended by the manufacturer. Supernatants were col-
lected 48 h after transfection. Concentrations for each CCL21
form present in the supernatants were roughly estimated
by western blotting by comparison with known amounts
of recombinant CCL21.
Chemotaxis assays
Chemotaxis in response to chemokines CCL21 and CCL19 was
determined by measuring the number of cells migrating through
a polycarbonate ﬁlter (5-µm pore size) in 24-well transwell
chambers (Costar Europe). The upper chamber included 1 ×
105 DCs diluted in 100 µL of RPMI 1640 medium and 0.1%
bovine serum albumin, and the lower chamber contained
600 µL of the same medium with or without chemokines (at
200 ng/mL, unless otherwise indicated). DCs that migrated to
the bottom chamber (after 2 h at 37°C) and inputs were counted
by ﬂow cytometry using CellQuest software (BD Biosciences).
Percentage of migration was expressed relative to the number of
input cells after subtracting the number of cells migrated in the
absence of chemokines from the values obtained in the presence
of chemokine in the lower chamber. COS7 cell supernatants
containing CCL21-wt and CCL21-stop forms were used at
doses estimated to bewithin a range between 100 and 200 ng/mL.
Nucleofection in DCs of siRNAs
Immature DCs (2–4 × 106) were transfected with 600 nmol of
each siRNA (Ambion) using the Amaxa human dendritic cell
nucleofector kit following the manufacturer’s instructions.
Sense siRNAs used were: GAPDH: (ref 4390850, Ambion);
ST8SiaAIV:CCUCCUACCUGAAGUUUCAtt; NRP2:
AGAUUGUCCUCAACUUCAAtt. One hour later, DCs were
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matured by the addition of 100 ng/mL of LPS. Experiments
were carried out 36 h later. Downregulation of protein expres-
sion levels for NRP2 was assayed by western blotting using an
anti-NRP2 antibody. ST8SiaIV downregulation was indirectly
determined by detection of PSA levels by western blotting
using the 735 antibody.
Signaling assays
Signaling experiments were basically as described (Riol-Blanco
et al. 2005). DCs were stimulated with CCL21 at 200 ng/mL for
the indicated times. JNK and Akt activation was assayed with
anti-phospho-JNK(Thr183/Tyr185) and anti-phospho-Akt
(Ser473) antibodies, respectively.
Statistical analysis
Statistical analyses were performed using the paired Student’s
t-test. A value of P equal to or less than 0.05 was considered
signiﬁcant.
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